Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome

被引：15

作者：

Ito, S ^{[1
]}

Ishida, Y ^{[1
]}

Murai, K ^{[1
]}

Kuriya, S ^{[1
]}

机构：

[1] Iwate Med Univ, Sch Med, Dept Internal Med 3, Div Hematol, Morioka, Iwate 0208505, Japan

来源：

LEUKEMIA RESEARCH | 2001年 / 25卷 / 03期

关键词：

minimal residual disease; CD45; gating; aberrant antigen; flow cytometry; acute leukemia; myelodysplastic syndrome;

D O I：

10.1016/S0145-2126(00)00127-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To evaluate the availability of quantification of blasts with aberrant antigen expression (AAE) using CD45 gating for minimal residual disease (MRD), 15 patients with acute leukemia (AL) and myelodysplastic syndrome (MDS) were studied. In patients with complete remission (CR), the frequency of blasts with AAE (%AAE) by CD45/side scatter (SSC) gating was significantly higher than that by the traditional forward scatter (FSC)/SSC combination (median, 4.1 vs. 0.3%, P < 0.0001). We also demonstrated two representative cases, in which leukemia relapse could be predicted before 3 weeks and the early treatment for MRD could be performed for MRD after allogeneic bone marrow transplantation (BMT). These results indicate that this procedure is very useful for the evaluation of the quality of CR. (C) 2001 Elsevier Science Ltd. All rights reserved.

引用

页码：205 / 211

页数：7

共 31 条

[1] PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, HR ;

SULTAN, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&

[2] PROPOSED REVISED CRITERIA FOR THE CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA - A REPORT OF THE FRENCH-AMERICAN-BRITISH COOPERATIVE GROUP [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, HR ;

SULTAN, C .

ANNALS OF INTERNAL MEDICINE, 1985, 103 (04) :620-625

[3] Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemia [J].

Bernell, P ;

Arvidsson, I ;

Jacobsson, B ;

Hast, R .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (04) :666-672

[4] IMMUNOPHENOTYPING OF ACUTE-LEUKEMIA BY FLOW CYTOMETRIC ANALYSIS - USE OF CD45 AND RIGHT-ANGLE LIGHT SCATTER TO GATE ON LEUKEMIC BLASTS IN 3-COLOR ANALYSIS [J].

BOROWITZ, MJ ;

GUENTHER, KL ;

SHULTS, KE ;

STELZER, GT .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (05) :534-540

[5] THE IMMUNOLOGICAL DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA [J].

CAMPANA, D ;

COUSTANSMITH, E ;

JANOSSY, G .

BLOOD, 1990, 76 (01) :163-171

[6] Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia [J].

Ciudad, J ;

San Miguel, JF ;

López-Berges, MC ;

Vidriales, B ;

Valverde, B ;

Ocqueteau, M ;

Mateos, G ;

Caballero, MD ;

Hernández, J ;

Moro, MJ ;

Mateos, MV ;

Orfao, A .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) :3774-3781

[7]

DOWNING JR, 1993, BLOOD, V81, P2860

[8] Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: A metaphase-FISH study [J].

ElRifai, W ;

Ruutu, T ;

Vettenranta, K ;

Temtamy, S ;

Knuutila, S .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) :365-369

[9] Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission [J].

Engel, H ;

Goodacre, A ;

Keyhani, A ;

Jiang, SW ;

Van, NT ;

Kimmel, M ;

SanchezWilliams, G ;

Andreeff, M .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (01) :64-75

[10]

Ferrara F, 1999, CANCER, V86, P2006, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2006::AID-CNCR18>3.3.CO

← 1 2 3 4 →